Abstract
IntroductionPhysical activity (PA) is protective against type 2 diabetes (T2D). However, data on pragmatic long-term interventions to reduce the risk of developing T2D via increased PA are lacking. This study investigated the cost-effectiveness of a pragmatic PA intervention in a multiethnic population at high risk of T2D.Materials and methodsWe adapted the School for Public Health Research diabetes prevention model, using the PROPELS trial data and analyses of the NAVIGATOR trial. Lifetime costs, lifetime quality-adjusted life years (QALYs), and incremental cost-effectiveness ratios (ICERs) were calculated for each intervention (Walking Away (WA) and Walking Away Plus (WA+)) versus usual care and compared with National Institute for Health and Care Excellence’s willingness-to-pay of £20 000–£30 000 per QALY gained. We conducted scenario analyses on the outcomes of the PROPELS trial data and a threshold analysis to determine the change in step count that would be needed for the interventions to be cost-effective.ResultsEstimated lifetime costs for usual care, WA, and WA+ were £22 598, £23 018, and £22 945, respectively. Estimated QALYs were 9.323, 9.312, and 9.330, respectively. WA+ was estimated to be more effective and cheaper than WA. WA+ had an ICER of £49 273 per QALY gained versus usual care. In none of our scenario analyses did either WA or WA+ have an ICER below £20 000 per QALY gained. Our threshold analysis suggested that a PA intervention costing the same as WA+ would have an ICER below £20 000/QALY if it were to achieve an increase in step count of 500 steps per day which was 100% maintained at 4 years.ConclusionsWe found that neither WA nor WA+ was cost-effective at a limit of £20 000 per QALY gained. Our threshold analysis showed that interventions to increase step count can be cost-effective at this limit if they achieve greater long-term maintenance of effect.Trial Registration numberISRCTN registration:ISRCTN83465245: The PRomotion Of Physical activity through structuredEducation with differing Levels of ongoing Support for those with pre-diabetes (PROPELS)https://doi.org/10.1186/ISRCTN83465245.
Funder
National Institute for Health Research Health Technology Assessment programme
NHS England
NIHR Leicester Biomedical Research Centre
University of Sheffield Institutional Open Access Fund
NHS Leicester City Clinical Commissioning Group
NHS East Leicestershire and Rutland Clinical Commissioning Group
NHS West Leicestershire Clinical Commissioning Group
Reference36 articles.
1. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition
2. Diabetes UK . The cost of diabetes; 2014.
3. Diabetes UK . Number of people with diabetes reaches 4.8 million; 2020. Available: https://www.diabetes.org.uk/about_us/news/diabetes-prevalence-2019 [Accessed 25 Sep 2020].
4. Diabetes UK . Reduce your risk of type 2 diabetes. Available: https://www.diabetes.org.uk/preventing-type-2-diabetes/can-diabetes-be-prevented [Accessed 25 Sep 2020].
5. Effectiveness of a Pragmatic Education Program Designed to Promote Walking Activity in Individuals With Impaired Glucose Tolerance